Generic Name

Zolmitriptan

Brand Names
Zolmiptriptan, ZOMIG
FDA approval date: May 14, 2013
Classification: Serotonin-1b and Serotonin-1d Receptor Agonist
Form: Spray, Tablet

What is Zolmiptriptan (Zolmitriptan)?

Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan orally disintegrating tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan orally disintegrating tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan orally disintegrating tablets are administered to treat any subsequent attacks., Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks., Safety and effectiveness of zolmitriptan orally disintegrating tablets have not been established for cluster headache. Zolmitriptan orally disintegrating tablets are a serotonin 1B/1D receptor agonist indicated for the acute treatment of migraine with or without aura in adults Limitations of Use :, Use only after a clear diagnosis of migraine has been established , Not indicated for the prophylactic therapy of migraine , Not indicated for the treatment of cluster headache

Brand Information